Hypoxia-inducible transcription factors stabilization in the thick ascending limb protects against ischemic acute kidney injury

Journal of the American Society of Nephrology

Volumn 22, Issue 11, 2011, Pages 2004-2015

  Schley, Gunnar ^a   Klanke, Bernd ^a   Schödel, Johannes ^a   Forstreuter, Frauke ^b   Shukla, Deepa ^b   Kurtz, Armin ^c   Amann, Kerstin ^a   Wiesener, Michael S ^a   Rosen, Seymour ^d   Eckardt, Kai Uwe ^a   Maxwell, Patrick H ^b   Willam, Carsten ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID; TAMM HORSFALL GLYCOPROTEIN; VON HIPPEL LINDAU PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE DELETION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REPERFUSION INJURY; THICK ASCENDING LIMB;

EID: 80555148901     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010121249     Document Type: Article

References (69)

1. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML: Incidence and outcomes of acute kidney injury in intensive care units: A Veterans Administration study. Crit Care Med 37: 2552-2558, 2009
2. Brezis M, Rosen S: Hypoxia of the renal medulla - its implications for disease. N Engl J Med 332: 647-655, 1995
3. Eckardt KU, Bernhardt WM, Weidemann A, Warnecke C, Rosenberger C, Wiesener MS, Willam C: Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl: S46-S51, 2005
4. Heyman SN, Rosenberger C, Rosen S: Experimental ischemia-reperfusion: Biases and myths-the proximal vs. distal hypoxic tubular injury debate revisited. Kidney Int 77: 9-16, 2010
5. Heyman SN, Shina A, Brezis M, Rosen S: Proximal tubular injury attenuates outer medullary hypoxic damage: studies in perfused rat kidneys. Exp Nephrol 10: 259-266, 2002 (Pubitemid 34827783)
6. Lieberthal W, Nigam SK: Acute renal failure. I. Relative importance of proximal vs. distal tubular injury. Am J Physiol 275: F623-F631, 1998
7. Ross BD, Espinal J, Silva P: Glucose metabolism in renal tubular function. Kidney Int 29: 54-67, 1986 (Pubitemid 16165680)
8. Aravindan N, Shaw A: Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. Ren Fail 28: 25-35, 2006 (Pubitemid 43247287)
9. Brezis M, Rosen S, Silva P, Epstein FH: Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 25: 65-72, 1984 (Pubitemid 14159386)
10. Patak RV, Fadem SZ, Lifschitz MD, Stein JH: Study of factors which modify the development of norepinephrine-induced acute renal failure in the dog. Kidney Int 15: 227-237, 1979 (Pubitemid 9256597)
11. Aydin G, Okiye SE, Zincke H: A comparative study of several agents alone and combined in protection of the rodent kidney from warm ischaemia: Methylprednisolone, propranolol, furosemide, mannitol, and adenosine triphosphate-magnesium chloride. Urol Res 11: 105-109, 1983 (Pubitemid 13035419)
12. Epstein FH: Oxygen and renal metabolism. Kidney Int 51: 381-385, 1997
13. Lewis RM, Rice JH, Patton MK, Barnes JL, Nickel AE, Osgood RW, Fried T, Stein JH: Renal ischemic injury in the dog: Characterization and effect of various pharmacologic agents. J Lab Clin Med 104: 470-479, 1984 (Pubitemid 14015743)
14. Mason J, Kain H, Welsch J, Schnermann J: The early phase of experimental acute renal failure. VI. The influence of furosemide. Pflugers Arch 392: 125-133, 1981 (Pubitemid 12194853)
15. Ufferman RC, Jaenike JR, Freeman RB, Pabico RC: Effects of furosemide on low-dose mercuric chloride acute renal failure in the rat. Kidney Int 8: 362-367, 1975
16. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420, 1994 (Pubitemid 24348355)
17. Kaelin WG Jr., Ratcliffe PJ: Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 30: 393-402, 2008
18. Semenza GL: HIF-1 inhibitors for cancer therapy: From gene expression to drug discovery. Curr Pharm Des 15: 3839-3843, 2009
19. Haase VH: Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299: F1-F13, 2010
20. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygendependent proteolysis. Nature 399: 271-275, 1999 (Pubitemid 29246458)
21. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIF-alpha to the von Hippel- Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472, 2001 (Pubitemid 32335942)
22. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr.: HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464-468, 2001 (Pubitemid 32335941)
23. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001 (Pubitemid 32972036)
24. Rosenberger C, Mandriota S, Jurgensen JS, Wiesener MS, Horstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721-1732, 2002 (Pubitemid 34700596)
25. Schödel J, Bohr D, Klanke B, Schley G, Schlotzer-Schrehardt U, Warnecke C, Kurtz A, Amann K, Eckardt KU, Willam C: Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells. Kidney Int 78: 857-867, 2010
26. Schödel J, Klanke B, Weidemann A, Buchholz B, Bernhardt W, Bertog M, Amann K, Korbmacher C, Wiesener M, Warnecke C, Kurtz A, Eckardt KU, Willam C: HIF-prolyl hydroxylases in the rat kidney: Physiologic expression patterns and regulation in acute kidney injury. Am J Pathol 174: 1663-1674, 2009
27. Matsumoto M, Makino Y, Tanaka T, Tanaka H, Ishizaka N, Noiri E, Fujita T, Nangaku M: Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 14: 1825-1832, 2003 (Pubitemid 36750477)
28. Tanaka T, Kojima I, Ohse T, Inagi R, Miyata T, Ingelfinger JR, Fujita T, Nangaku M: Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity. Am J Physiol Renal Physiol 289: F1123-F1133, 2005 (Pubitemid 41447069)
29. Bernhardt WM, Campean V, Kany S, Jurgensen JS, Weidemann A, Warnecke C, Arend M, Klaus S, Gunzler V, Amann K, Willam C, Wiesener MS, Eckardt KU: Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 17: 1970-1978, 2006 (Pubitemid 44036181)
30. Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Campean V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C: HIF activation protects from acute kidney injury. J Am Soc Nephrol 19: 486-494, 2008 (Pubitemid 351355392)
31. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH: Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 19: 39-46, 2008
32. Kapitsinou PP, Haase VH: The VHL tumor suppressor and HIF: Insights from genetic studies in mice. Cell Death Differ 15: 650-659, 2008 (Pubitemid 351405068)
33. Iguchi M, Kakinuma Y, Kurabayashi A, Sato T, Shuin T, Hong SB, Schmidt LS, Furihata M: Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney. Nephron Exp Nephrol 110: e82-e90, 2008
34. Haase VH, Glickman JN, Socolovsky M, Jaenisch R: Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci U S A 98: 1583-1588, 2001 (Pubitemid 32165542)
35. Rankin EB, Tomaszewski JE, Haase VH: Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 66: 2576-2583, 2006
36. Frew IJ, Thoma CR, Georgiev S, Minola A, Hitz M, Montani M, Moch H, Krek W: pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation. Embo J 27: 1747-1757, 2008
37. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117: 3810-3820, 2007 (Pubitemid 350224091)
38. Kimura K, Iwano M, Higgins DF, Yamaguchi Y, Nakatani K, Harada K, Kubo A, Akai Y, Rankin EB, Neilson EG, Haase VH, Saito Y: Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 295: F1023-F1029, 2008
39. Kaelin WG Jr.: Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2: 673-682, 2002
40. Willam C, Masson N, Tian YM, Mahmood SA, Wilson MI, Bicknell R, Eckardt KU, Maxwell PH, Ratcliffe PJ, Pugh CW: Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis. Proc Natl Acad Sci U S A 99: 10423-10428, 2002
41. Riazi S, Tiwari S, Sharma N, Rash A, Ecelbarger CM: Abundance of the Na-K-2Cl cotransporter NKCC2 is increased by high-fat feeding in Fischer 344 X Brown Norway (F1) rats. Am J Physiol Renal Physiol 296: F762-F770, 2009
42. Brines M, Cerami A: Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise. Kidney Int 70: 246-250, 2006 (Pubitemid 44086573)
43. Sugden MC, Holness MJ: Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 284: E855-E862, 2003 (Pubitemid 36444020)
44. Shanley PF, Rosen MD, Brezis M, Silva P, Epstein FH, Rosen S: Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney. Am J Pathol 122: 462-468, 1986 (Pubitemid 16017666)
45. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115: 610-621, 2005 (Pubitemid 40322235)
46. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135-4142, 1998 (Pubitemid 28103282)
47. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV: Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290: F517-F529, 2006 (Pubitemid 43725006)
48. Bonventre JV, Zuk A: Ischemic acute renal failure: An inflammatory disease? Kidney Int 66: 480-485, 2004 (Pubitemid 38981982)
49. Lieberthal W, Nigam SK: Acute renal failure. II. Experimental models of acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol 278: F1-F12, 2000 (Pubitemid 30106121)
50. Srichai MB, Hao C, Davis L, Golovin A, Zhao M, Moeckel G, Dunn S, Bulus N, Harris RC, Zent R, Breyer MD: Apoptosis of the thick ascending limb results in acute kidney injury. J Am Soc Nephrol 19: 1538-1546, 2008
51. Safirstein R: Gene expression in nephrotoxic and ischemic acute renal failure. J Am Soc Nephrol 4: 1387-1395, 1994
52. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, Viltard M, Yu W, Forster CS, Gong G, Liu Y, Kulkarni R, Mori K, Kalandadze A, Ratner AJ, Devarajan P, Landry DW, D'Agati V, Lin CS, Barasch J: The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 17: 216-222, 2011
53. Gobe GC, Johnson DW: Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. Int J Biochem Cell Biol 39: 1551-1561, 2007 (Pubitemid 47088318)
54. Jang HR, Rabb H: The innate immune response in ischemic acute kidney injury. Clin Immunol 130: 41-50, 2009
55. Kojima I, Tanaka T, Inagi R, Kato H, Yamashita T, Sakiyama A, Ohneda O, Takeda N, Sata M, Miyata T, Fujita T, Nangaku M: Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney. J Am Soc Nephrol 18: 1218-1226, 2007 (Pubitemid 46536908)
56. Bernhardt WM, Eckardt KU: Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care 14: 621-626, 2008
57. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, Simon MC, Keith B, Haase VH: Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117: 1068-1077, 2007 (Pubitemid 46556763)
58. Warnecke C, Weidemann A, Volke M, Schietke R, Wu X, Knaup KX, Hackenbeck T, Bernhardt W, Willam C, Eckardt KU, Wiesener MS: The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp Cell Res 314: 2016-2027, 2008
59. Brezis M, Agmon Y, Epstein FH: Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol 267: F1059-F1062, 1994 (Pubitemid 124005388)
60. Brezis M, Heyman SN, Epstein FH: Determinants of intrarenal oxygenation. II. Hemodynamic effects. Am J Physiol 267: F1063-F1068, 1994 (Pubitemid 124005389)
61. Katz AI, Doucet A, Morel F: Na-K-ATPase activity along the rabbit, rat, and mouse nephron. Am J Physiol 237: F114-F120, 1979 (Pubitemid 10241377)
62. Biju MP, Akai Y, Shrimanker N, Haase VH: Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent. Am J Physiol Renal Physiol 289: F1217-F1226, 2005 (Pubitemid 41681357)
63. Aragones J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P: Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40: 170-180, 2008 (Pubitemid 351171394)
64. Nangaku M, Kojima I, Tanaka T, Ohse T, Kato H, Fujita T: Novel drugs and the response to hypoxia: HIF stabilizers and prolyl hydroxylase. Recent Patents Cardiovasc Drug Discov 1: 129-139, 2006
65. Yan L, Colandrea VJ, Hale JJ: Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: Small molecule-based therapeutics for anemia. Expert Opin Ther Pat 20: 1219-1245, 2010
66. Bernhardt WM, Wiesener MS, Scigalla P, Chou J, Schmieder RE, Gunzler V, Eckardt KU: Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol 21: 2151-2156, 2010
67. Weidemann A, Krohne TU, Aguilar E, Kurihara T, Takeda N, Dorrell MI, Simon MC, Haase VH, Friedlander M, Johnson RS: Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 58: 1177-1185, 2010
68. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ, Maxwell PH: Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92: 2260-2268, 1998 (Pubitemid 28452966)
69. Vitzthum H, Castrop H, Meier-Meitinger M, Riegger GA, Kurtz A, Kramer BK, Wolf K: Nephron specific regulation of chloride channel CLC-K2 mRNA in the rat. Kidney Int 61: 547-554, 2002 (Pubitemid 34102595)